Stay updated on ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial

Sign up to get notified when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T16:39:39.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed outdated notices (including the lapse in government funding notice and Revision: v3.4.1), reflecting minor site maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T01:56:18.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with NIH Clinical Center status and updated the page version to Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T23:16:39.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Additions include Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0; Deletions include Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. These are minor UI/metadata changes and do not alter core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T20:17:53.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page; this is a minor site version update and does not modify study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-20T14:42:00.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page now displays a Locations section with Brussels Capital and Namur as study sites, replacing the prior Brussels Capital Locations and Namur Locations entries. Footer updates remove the HHS Vulnerability Disclosure and the page revision is updated to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-22T22:32:41.000Z thumbnail image

Stay in the know with updates to ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.